Most peptides in research were copied from something the body already makes. Selank is one of them. It's a tweaked version of a tiny protein fragment called tuftsin, which the human immune system uses for signaling.
How researchers got to Selank
Plain tuftsin breaks down too quickly to be useful as a research tool. So Russian scientists modified its structure to make it more stable, and Selank was the result. It's mostly studied for two things: anxiety-like behavior in animal models and effects on memory and learning tasks.
What labs have observed
In rodent studies, Selank has been associated with reductions in anxiety-related behaviors without the sedation often seen with traditional anxiety drugs. Other research looks at how it affects BDNF — a protein nicknamed "fertilizer for the brain" because of its role in keeping neurons healthy.
Some studies have also tested Selank's effects on enkephalins, the body's own pain-modulating molecules, and on certain neurotransmitter systems involving serotonin and dopamine.
Why it's interesting
Selank gives scientists a way to study peptide-based modulation of mood and cognition without the side-effect profile of older anxiety medications. That's the appeal — a cleaner research tool.
Important: Selank is for laboratory and research use only. It is not approved for human use.